PackGene Biotech
PackGene Biotech: Pioneering R&D and CRO/CDMO services for gene and cell therapy since 2014.
Founded
2014PackGene Biotech: Pioneering R&D and CRO/CDMO services for gene and cell therapy since 2014.
Founded in 2014 and headquartered in Guangzhou, China, PackGene Biotech is dedicated to advancing gene and cell therapy through its comprehensive CRO/CDMO services. The company's mission is to accelerate the development of gene therapies by providing high-quality, efficient solutions for researchers and developers. PackGene offers a range of services including AAV and Lentivirus vector production, plasmid design through their piVector Designer tool, and free cloning with bundled virus or plasmid options. Their market focus is on supporting gene therapy and cell therapy research with unmatched speed and quality.
PackGene Biotech has made significant strides in the biotech industry, attracting notable investors and forming partnerships with leading research institutions. The company has hosted webinars addressing current challenges in rAAV manufacturing processes, showcasing their expertise in large-scale GMP production. Their innovative solutions have positioned them as a key player in the gene therapy sector, contributing to advancements in medical research and therapeutic development.
Companies similar to PackGene Biotech include VectorBuilder, Apertura Gene Therapy, VintaBio and Exegenesis Bio.
PackGene Biotech was founded in 2014.
PackGene Biotech's headquarters is located in Houston, TX, US.
PackGene Biotech's most recent funding round was for CN¥100M (CNY) in December 2023.
As of Dec 1, 2023, PackGene Biotech has raised a total of CN¥100M (CNY).
PackGene Biotech has 200 employees as of Feb 4, 2024.
VintaBio
vintabio.com
